For more than a decade, the Association for Corporate Growth – New Jersey, a prestigious organization serving dealmakers and business leaders who collectively focus on driving growth, has proudly hosted an elegant evening designed specifically for senior executives across a wide range of industries.
Over the years, this annual iconic event has become recognized and embraced for providing a unique opportunity for business leaders to network with each other during a lively cocktail reception followed by a formal dinner.
Throughout the evening, the room is filled with a powerful energy, buoyed by dynamic interactions and diverse opinions as people come together to exchange ideas and share experiences. Past attendees have represented companies that include Bristol Myers Squibb, LPS Industries, Johnson & Johnson Consumer, Dr. Praeger’s, Church & Dwight, Hackensack Meridian Health, ADP and Opici Wine Distributors, to name just a few.
We are thrilled that this distinctive tradition will continue on Nov. 1 as ACG N.J. is honored to present, once again, an evening that originated as a way to connect corporate owners, senior leaders and C-suite decision-makers. In the midst of the beautiful setting created by the Pleasantdale Chateau, one of the state’s most highly sought-after venues, participants will have the chance to catch up with old friends while also making new contacts in an exclusive environment aimed at encouraging the expansion of existing relationships and forging new ones as well.
In the past, this evening has been further distinguished by the keen insights and inspiring observations that have been offered by the dinner speakers.
This year will be no different! In fact, everyone’s expectations will not only be met, but exceeded, when Bob Hugin, retired chairman and CEO of Celgene Corp. and a well-respected leader in the political, life sciences, technology and biopharmaceutical fields in New Jersey, steps up to the podium.
Hugin truly needs no introduction! He is the chair of the New Jersey Republican State Committee and he is a founding board member of the Garden State Initiative, a nonpartisan economic focused think tank, and a charter trustee of Princeton University. He is also a longstanding member of the board of trustees of Family Promise, a national nonprofit network assisting homeless families.
Additionally, Hugin serves as director of the Parker Institute for Cancer Immunotherapy and is a past chair of the Darden School Foundation, University of Virginia. He is also director of Chubb Ltd. and Biohaven Pharmaceuticals.However, Hugin is most well-known in New Jersey for his long-time role as the CEO of Celgene, a global innovative biopharmaceutical company focused on the discovery, development and commercialization of transformational therapies for unmet medical needs. Celgene produces cancer and immunology drugs, including Revlimid (lenalidomide), its major product, which is used in the treatment of multiple myeloma, and also in certain anemias. A subsidiary of Bristol Myers Squibb, the company is headquartered in nearby Summit.
In March 2016, Bob retired from his position as CEO and accepted the role of executive chairman. Two years later, in 2018, he stepped down as chairman and CEO of Celgene Corp.
He is past chairman of the boards of the Pharmaceutical Research and Manufacturers of America and the Healthcare Institute of New Jersey. Prior to joining Celgene, Hugin was a managing director with J.P. Morgan & Co. Inc.
We urge you to take advantage of this extraordinary evening. We invite you to enjoy stimulating discussions, enlightening conversations, peer-to-peer networking and a delectable menu at:
The Pleasantdale Chateau, West Orange
Wednesday, Nov. 1
This one-of-a-kind evening begins with cocktails and hors d’oeuvres at 5 p.m.
The evening concludes with dessert and after-dinner cocktails from 8-9 p.m.
Please register by Oct. 27 here.